Zydus Cadila receives USFDA final nod for Macitentan Tablets; Stock gains 1%

With this approval, Zydus is eligible for 180 days of shared generic drug exclusivity for Macitentan Tablets, 10 mg.

from India Infoline News Service https://ift.tt/2PISPAd